SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals
TEVA 34.95-3.5%Feb 4 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Uncle Mikey who wrote (109)11/11/1997 11:29:00 PM
From: James Silverman  Read Replies (1) of 340
 
As far as I can tell, Copaxone is doing fine. Because Teva is unlike many US and Canadian counterparts and not prone to hype, they are taking their time before revealing Copaxone numbers. This has created worry. I see the stock doing quite fine in 1998 as it becomes evident that copaxone indeed will contribute nicely to Teva's bottom line.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News